Pneumococcal pneumonia

Results: 557



#Item
1Meet Ryan Carpenter Ryan was born and raised in Moses Lake, WA. He grew up having family in Odessa, as his mother was a Zeiler. They had many visits growing up to see grandparents

Meet Ryan Carpenter Ryan was born and raised in Moses Lake, WA. He grew up having family in Odessa, as his mother was a Zeiler. They had many visits growing up to see grandparents

Add to Reading List

Source URL: www.omhc.org

Language: English - Date: 2015-11-05 16:55:50
2LASCCO Announces Positive Scientific Advice Meeting with MHRA and Plans a First-In-Man Clinical Trial with CAL02 in Patients with Severe Pneumococcal Pneumonia GENEVA, SWITZERLAND, 22 October 2014 – LASCCO SA has held

LASCCO Announces Positive Scientific Advice Meeting with MHRA and Plans a First-In-Man Clinical Trial with CAL02 in Patients with Severe Pneumococcal Pneumonia GENEVA, SWITZERLAND, 22 October 2014 – LASCCO SA has held

Add to Reading List

Source URL: www.lascco.com

Language: English - Date: 2014-10-23 10:01:03
3HIN Logo_Color_Master_Standard Logo_CS2

HIN Logo_Color_Master_Standard Logo_CS2

Add to Reading List

Source URL: neahealthyfutures.org

Language: English - Date: 2015-08-12 16:11:35
4Combioxin SA announces first patient enrolled in first-in-man study with CAL02 in patients with severe pneumococcal pneumonia 23 March 2016 GENEVA, SWITZERLAND – Combioxin SA announces that the first patient has been r

Combioxin SA announces first patient enrolled in first-in-man study with CAL02 in patients with severe pneumococcal pneumonia 23 March 2016 GENEVA, SWITZERLAND – Combioxin SA announces that the first patient has been r

Add to Reading List

Source URL: www.lascco.com

Language: English - Date: 2016-03-24 08:02:57
5ppsv - what you need to know- 508 compliant

ppsv - what you need to know- 508 compliant

Add to Reading List

Source URL: www.c-uphd.org

Language: English - Date: 2012-09-26 11:46:03
6Combioxin receives Clinical Trial Authorization to initiate a first-in-man study with CAL02 in patients with severe pneumococcal pneumonia GENEVA, SWITZERLAND, 12 January 2016 – Combioxin SA is pleased to announce that

Combioxin receives Clinical Trial Authorization to initiate a first-in-man study with CAL02 in patients with severe pneumococcal pneumonia GENEVA, SWITZERLAND, 12 January 2016 – Combioxin SA is pleased to announce that

Add to Reading List

Source URL: www.lascco.com

Language: English - Date: 2016-01-12 07:22:29
7BATTLING INFECTIONS OF THE CENTRAL NERVOUS SYSTEM Organisms, Risk Factors, and Laboratory Diagnostics Blake W. Buchan, PhD, D(ABMM) Email: Phone:

BATTLING INFECTIONS OF THE CENTRAL NERVOUS SYSTEM Organisms, Risk Factors, and Laboratory Diagnostics Blake W. Buchan, PhD, D(ABMM) Email: Phone:

Add to Reading List

Source URL: www.slh.wisc.edu

Language: English - Date: 2016-05-09 14:45:04
8Microbial ecology of the infant nasopharynx: Impact of the PCV-7 vaccination Martin Antonio PhD MRC Laboratories, The Gambia Presentation at

Microbial ecology of the infant nasopharynx: Impact of the PCV-7 vaccination Martin Antonio PhD MRC Laboratories, The Gambia Presentation at

Add to Reading List

Source URL: hmpdacc.org

Language: English - Date: 2014-02-26 12:33:20
9Research Articles Mortality Reductions for Older Adults Differ by Race/Ethnicity and Gender Since the Introduction of Adult and Pediatric Pneumococcal Vaccines

Research Articles Mortality Reductions for Older Adults Differ by Race/Ethnicity and Gender Since the Introduction of Adult and Pediatric Pneumococcal Vaccines

Add to Reading List

Source URL: people.iq.harvard.edu

Language: English - Date: 2011-08-04 16:12:24
10ONE YEAR ON Delivering on the promise of vaccines for all Save the Children works in more than 120 countries. We save children’s lives. We fight for their rights.

ONE YEAR ON Delivering on the promise of vaccines for all Save the Children works in more than 120 countries. We save children’s lives. We fight for their rights.

Add to Reading List

Source URL: www.savethechildren.nl

Language: English - Date: 2012-10-03 02:27:01